📰 Nasdaq Itrm News
Page 2 - Nasdaq Itrm News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Itrm. Real-time updates on events, politics, business and more.
July 12, 2023
Iterum Therapeutics plc (NASDAQ:ITRM – Get Free Report)’s stock price shot up 2.7% during mid-day trading on Tuesday . The company traded as high as $1.17 and last traded at $1.15. 23,660 shares were traded during mid-day trading, a decline of 65% from the average session volume of 67,273 shares. The stock had previously closed […]
May 16, 2023
Iterum Therapeutics plc (NASDAQ:ITRM – Get Rating) saw a large decline in short interest in April. As of April 30th, there was short interest totalling 76,400 shares, a decline of 26.5% from the April 15th total of 103,900 shares. Based on an average daily volume of 63,500 shares, the short-interest ratio is presently 1.2 days. […]
April 2, 2023
Iterum Therapeutics plc (NASDAQ:ITRM – Get Rating) saw a large drop in short interest in March. As of March 15th, there was short interest totalling 154,400 shares, a drop of 15.5% from the February 28th total of 182,700 shares. Based on an average daily volume of 101,600 shares, the short-interest ratio is presently 1.5 days. […]
April 2, 2023
Iterum Therapeutics plc (NASDAQ:ITRM – Get Rating) was the target of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 154,400 shares, a decrease of 15.5% from the February 28th total of 182,700 shares. Based on an average daily volume of 101,600 shares, the […]
April 2, 2023
Iterum Therapeutics plc (NASDAQ:ITRM – Get Rating) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 154,400 shares, a drop of 15.5% from the February 28th total of 182,700 shares. Approximately 1.2% of the shares of the company are sold short. Based on […]
August 17, 2022
DUBLIN, Ireland and CHICAGO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical...
May 29, 2022
Iterum Therapeutics plc (NASDAQ:ITRM – Get Rating) saw a significant drop in short interest in May. As of May 15th, there was short interest totalling 2,720,000 shares, a drop of 34.9% from the April 30th total of 4,180,000 shares. Approximately 1.5% of the shares of the company are sold short. Based on an average daily […]
May 16, 2022
Iterum Therapeutics (NASDAQ:ITRM – Get Rating) issued its earnings results on Friday. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.05) by $0.03, Fidelity Earnings reports. Shares of ITRM opened at $0.22 on Monday. The firm has a market cap of $39.95 million, a P/E ratio of […]
May 15, 2022
Iterum Therapeutics plc (NASDAQ:ITRM – Get Rating) was the target of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 4,180,000 shares, an increase of 56.6% from the April 15th total of 2,670,000 shares. Approximately 2.3% of the company’s shares are short sold. Based […]
April 18, 2022
Iterum Therapeutics plc (NASDAQ:ITRM – Get Rating) was the recipient of a large increase in short interest in March. As of March 31st, there was short interest totalling 3,550,000 shares, an increase of 27.2% from the March 15th total of 2,790,000 shares. Based on an average daily volume of 1,480,200 shares, the days-to-cover ratio is […]